Beta-blockers show up everywhere on Step 1 because they’re one of the cleanest ways to test receptor physiology, cardiac hemodynamics, and classic adverse effects—often all in the same question. If you can predict what happens when you block vs , you can usually eliminate wrong answers fast, especially when the vignette mixes asthma, diabetes, heart failure, and arrhythmias.
What are beta-blockers?
Beta-blockers are drugs that antagonize adrenergic receptors, decreasing sympathetic effects in the heart and (depending on selectivity) in other organs.
Core receptor targets (Step 1 framing)
- (heart, JG cells)
- HR (chronotropy), contractility (inotropy), AV conduction (dromotropy)
- renin release
- (lungs, vessels, uterus, liver, skeletal muscle vasculature)
- Bronchodilation, vasodilation, uterine relaxation, glycogenolysis
High-yield translation:
Blocking → slows the heart and decreases renin.
Blocking → can cause bronchospasm and blunt recovery from hypoglycemia.
Classification (know the “families”)
1) Cardioselective (-selective) beta-blockers
Examples: Metoprolol, Atenolol, Esmolol, Bisoprolol (also Nebivolol; see below)
Key point: Selectivity is dose-dependent—at higher doses they start hitting too.
2) Nonselective ( and )
Examples: Propranolol, Nadolol, Timolol, Pindolol
3) Mixed + blockers
Examples: Carvedilol, Labetalol
Mechanism: blockade + blockade → decreased SVR + decreased HR.
4) “Special features” you should recognize
- Esmolol: very short acting, IV; metabolized by RBC esterases → great for acute control
- Nebivolol: -selective + increases NO (vasodilation)
- Pindolol (and acebutolol): partial agonist activity (ISA) → less bradycardia; generally less favored in CAD/post-MI
Mechanism of action: link it to hemodynamics
In the heart
Blocking decreases:
- HR (negative chronotropy)
- Contractility (negative inotropy)
- AV nodal conduction (negative dromotropy)
- Automaticity (antiarrhythmic effect)
In the kidney
Blocking on JG cells → renin → Ang II and aldosterone → contributes to BP lowering.
Angina and MI: the “why it helps” pathophysiology
In stable angina, ischemia happens when myocardial O demand exceeds supply. Demand is driven by:
- HR
- Contractility
- Wall stress (preload/afterload)
Beta-blockers reduce demand mainly via HR and contractility → O consumption and increased diastolic filling time (better coronary perfusion).
Clinical uses (what Step 1 loves)
Hypertension
- Not always first-line in uncomplicated HTN, but common with comorbid:
- CAD (angina/post-MI)
- HFrEF (specific agents)
- Arrhythmias
- Hyperthyroidism symptoms
Ischemic heart disease (very high yield)
- Stable angina: reduce O demand
- Post-MI: reduce mortality by decreasing arrhythmias and remodeling risk
Do NOT use in Prinzmetal (variant) angina: blocking can allow unopposed vasoconstriction → worse coronary spasm (classic trap).
Heart failure (HFrEF)
Mortality benefit with:
- Metoprolol succinate
- Carvedilol
- Bisoprolol
Testable nuance: start when stable/euvolemic; can cause initial worsening due to negative inotropy.
Arrhythmias (especially supraventricular)
- Rate control in atrial fibrillation/flutter
- AVNRT prevention/termination (rate slowing through AV node)
- Some ventricular ectopy suppression post-MI
Aortic dissection (acute)
- Beta-blocker (often esmolol) to reduce shear stress by lowering HR and contractility before vasodilators.
Thyrotoxicosis/thyroid storm
- Propranolol decreases peripheral T4 → T3 conversion (extra mechanism).
Glaucoma
- Timolol ophthalmic: decreases aqueous humor production.
Performance anxiety / essential tremor / migraine prophylaxis
- Propranolol is classic.
How patients “present” on questions
Therapeutic effect vignettes
- Post-MI patient placed on metoprolol; HR decreases; fewer PVCs
- AF with rapid ventricular response; rate slows after IV esmolol/metoprolol
- HFrEF patient improves over weeks on carvedilol + ACEi
Toxicity vignettes
- Bradycardia + hypotension + fatigue
- Wheezing after nonselective beta-blocker in asthma/COPD
- Diabetic patient has hypoglycemia without tremor/palpitations (masked adrenergic symptoms)
- Cold extremities, erectile dysfunction, depression (classically described)
Diagnosis/recognition (Step-style pattern matching)
You usually “diagnose” beta-blocker effects clinically:
- Vitals: bradycardia, hypotension
- EKG: PR prolongation/AV block (from AV nodal slowing)
- Pulmonary: bronchospasm (esp nonselective)
- Metabolic: masked hypoglycemia; may affect lipid profile (less emphasized but fair game)
Beta-blocker overdose recognition
Classic triad-ish: bradycardia + hypotension + altered mental status (plus possible bronchospasm, hypoglycemia)
Treatment (high yield):
- Glucagon (increases cAMP independent of receptors)
- Supportive care: IV fluids, atropine for bradycardia, vasopressors as needed
- High-dose insulin therapy may be used clinically (more Step 2/clinical detail)
Adverse effects (HY list to memorize)
| Adverse effect | Mechanism/Notes | Biggest offenders |
|---|---|---|
| Bradycardia, AV block | AV nodal suppression | Any (dose-related) |
| Hypotension | CO (and block with carvedilol/labetalol) | All; mixed agents more |
| Bronchospasm | blockade prevents bronchodilation | Propranolol, Nadolol, Timolol |
| Masked hypoglycemia | blocks adrenergic warning signs (tremor, palpitations); sweating may persist | Nonselective > selective |
| Fatigue, depression, sleep disturbance | CNS penetration varies (lipophilic agents like propranolol more) | Propranolol (classic) |
| Sexual dysfunction | multifactorial | Class effect |
| Acute decompensation in HF | negative inotropy early on | starting/titrating too fast |
| Rebound tachycardia/HTN/angina | upregulated receptors if abruptly stopped | abrupt withdrawal |
Absolute Step 1 pearl: Do not abruptly discontinue—taper to avoid rebound sympathetic surge.
Contraindications & “be careful” scenarios
Asthma/COPD
- Avoid nonselective beta-blockers.
- If needed, choose -selective (metoprolol, atenolol) with caution.
Diabetes
- Risk: masking hypoglycemia + impaired glycogenolysis (more with nonselective).
Prinzmetal angina
- Avoid (may worsen vasospasm).
Severe bradycardia, high-grade AV block
- Avoid unless paced/closely monitored.
Treatment algorithms: where they fit (big-picture)
Stable angina (symptom control)
- Beta-blocker (reduces demand)
- Nitrates (reduce preload; acute relief)
- Calcium channel blockers (alternative; esp vasospasm)
AF rate control
- Beta-blocker or non-DHP CCB (verapamil/diltiazem) depending on context.
HFrEF mortality reduction
- ACEi/ARB/ARNI + evidence-based beta-blocker (metoprolol succinate/carvedilol/bisoprolol) + others (MRA, SGLT2 inhibitor) (details more Step 2, but the beta-blocker list is Step 1 classic).
High-yield associations & classic Step traps
“Unopposed alpha” concept
Nonselective beta blockade can leave vasoconstriction unopposed → can worsen vasospasm (Prinzmetal) and is a key concept in catecholamine states.
Pheochromocytoma (conceptual)
If using beta-blocker, alpha blockade must come first (phenoxybenzamine) to avoid hypertensive crisis from unopposed alpha stimulation.
Thyroid storm
Propranolol: symptom control + decreased T4→T3 conversion.
Glaucoma
Timolol decreases aqueous humor production (contrast with prostaglandin analogs like latanoprost which increase outflow).
Antiarrhythmic classification
Most beta-blockers are Class II antiarrhythmics → decrease SA/AV node activity.
First Aid cross-references (so you can quickly anchor this)
(Page numbers vary by edition—use these as section-based waypoints.)
- Cardiovascular Pharmacology → Antianginal drugs: beta-blockers reduce O demand (HR/contractility)
- Cardiovascular Pharmacology → Antihypertensives: beta-blocker classes; mixed blockers
- Cardiovascular Pharmacology → Antiarrhythmics (Class II): AV nodal slowing, increased PR interval
- Endocrine Pharmacology → Thyroid: propranolol in hyperthyroidism (T4→T3)
- Autonomics Pharmacology → Adrenergic antagonists: receptor selectivity and adverse effects
- Ophthalmology Pharm (often under autonomics): timolol for glaucoma
Rapid review (exam-day checklist)
- block: HR, contractility, renin
- Nonselective → bronchospasm + masked hypoglycemia more likely
- HFrEF mortality benefit: metoprolol succinate, carvedilol, bisoprolol
- Overdose antidote: glucagon
- Do not stop abruptly (rebound)
- Avoid in Prinzmetal
- Propranolol: performance anxiety, tremor, migraine; also blocks T4→T3